Clinical Trial Site

Tübingen 72076

0 studies enrolling now · 3 studies all time

What they study most

ANCA-Associated Vasculitis, Atypical Hemolytic Uremic Syndrome (aHUS), Atypical Hemolytic-Uremic Syndrome

Studies at this site

• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed